168 related articles for article (PubMed ID: 10560802)
1. Lactate- or bicarbonate-buffered solutions in continuous extracorporeal renal replacement therapies.
Kierdorf HP; Leue C; Arns S
Kidney Int Suppl; 1999 Nov; (72):S32-6. PubMed ID: 10560802
[TBL] [Abstract][Full Text] [Related]
2. Effects of lactate-buffered and lactate-free dialysate in CAVHD patients with and without liver dysfunction.
McLean AG; Davenport A; Cox D; Sweny P
Kidney Int; 2000 Oct; 58(4):1765-72. PubMed ID: 11012911
[TBL] [Abstract][Full Text] [Related]
3. Which bicarbonate concentration is adequate to lactate-buffered substitution fluids in maintenance hemofiltration?
Böhm R; Gladziwa U; Clasen W; Riehl J; Mann H; Sieberth HG
Clin Nephrol; 1994 Oct; 42(4):257-62. PubMed ID: 7834919
[TBL] [Abstract][Full Text] [Related]
4. Acid-base balance and substitution fluid during continuous hemofiltration.
Heering P; Ivens K; Thümer O; Braüse M; Grabensee B
Kidney Int Suppl; 1999 Nov; (72):S37-40. PubMed ID: 10560803
[TBL] [Abstract][Full Text] [Related]
5. The use of different buffers during continuous hemofiltration in critically ill patients with acute renal failure.
Heering P; Ivens K; Thümer O; Morgera S; Heintzen M; Passlick-Deetjen J; Willers R; Strauer BE; Grabensee B
Intensive Care Med; 1999 Nov; 25(11):1244-51. PubMed ID: 10654208
[TBL] [Abstract][Full Text] [Related]
6. Acid-base profile and predictors of metabolic acidosis in patients undergoing peritoneal dialysis with lactate- and bicarbonate-buffered peritoneal dialysis solutions.
Fourtounas C; Savidaki E; Roumelioti M; Dousdampanis P; Hardalias A; Kalliakmani P; Papachristou E; Drakopoulos A; Goumenos DS; Vlachojannis JG
Adv Perit Dial; 2006; 22():187-91. PubMed ID: 16983967
[TBL] [Abstract][Full Text] [Related]
7. Dialysate and replacement fluid composition for CRRT.
Aucella F; Di Paolo S; Gesualdo L
Contrib Nephrol; 2007; 156():287-96. PubMed ID: 17464138
[TBL] [Abstract][Full Text] [Related]
8. Do bicarbonate-based solutions for continuous renal replacement therapy offer better control of metabolic acidosis than lactate-containing fluids?
Agarwal B; Kovari F; Saha R; Shaw S; Davenport A
Nephron Clin Pract; 2011; 118(4):c392-8. PubMed ID: 21346374
[TBL] [Abstract][Full Text] [Related]
9. Continuous veno-venous haemodialysis with a novel bicarbonate dialysis solution: prospective cross-over comparison with a lactate buffered solution.
Zimmerman D; Cotman P; Ting R; Karanicolas S; Tobe SW
Nephrol Dial Transplant; 1999 Oct; 14(10):2387-91. PubMed ID: 10528662
[TBL] [Abstract][Full Text] [Related]
10. Electrolyte mass balance during CVVH: lactate vs. bicarbonate-buffered replacement fluids.
Tan HK; Uchino S; Bellomo R
Ren Fail; 2004 Mar; 26(2):149-53. PubMed ID: 15287198
[TBL] [Abstract][Full Text] [Related]
11. Randomized long-term evaluation of bicarbonate-buffered CAPD solution.
Feriani M; Kirchgessner J; La Greca G; Passlick-Deetjen J
Kidney Int; 1998 Nov; 54(5):1731-8. PubMed ID: 9844152
[TBL] [Abstract][Full Text] [Related]
12. Osmotic agents and buffers in peritoneal dialysis solution: monocyte cytokine release and in vitro cytotoxicity.
Plum J; Schoenicke G; Grabensee B
Am J Kidney Dis; 1997 Sep; 30(3):413-22. PubMed ID: 9292571
[TBL] [Abstract][Full Text] [Related]
13. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].
Nau B; Schmitt CP; Almeida M; Arbeiter K; Ardissino G; Bonzel KE; Edefonti A; Fischbach M; Haluany K; Misselwitz J; Kemper MJ; Rönnholm K; Wygoda S; Schaefer F;
BMC Nephrol; 2004 Oct; 5():14. PubMed ID: 15485574
[TBL] [Abstract][Full Text] [Related]
14. The acid-base effects of continuous hemofiltration with lactate or bicarbonate buffered replacement fluids.
Tan HK; Uchino S; Bellomo R
Int J Artif Organs; 2003 Jun; 26(6):477-83. PubMed ID: 12866653
[TBL] [Abstract][Full Text] [Related]
15. Bench-to-bedside review: treating acid-base abnormalities in the intensive care unit--the role of renal replacement therapy.
Naka T; Bellomo R
Crit Care; 2004 Apr; 8(2):108-14. PubMed ID: 15025771
[TBL] [Abstract][Full Text] [Related]
16. Effects of bicarbonate- and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients.
Barenbrock M; Hausberg M; Matzkies F; de la Motte S; Schaefer RM
Kidney Int; 2000 Oct; 58(4):1751-7. PubMed ID: 11012909
[TBL] [Abstract][Full Text] [Related]
17. Bicarbonate dialysate for continuous renal replacement therapy in intensive care unit patients with acute renal failure.
Leblanc M; Moreno L; Robinson OP; Tapolyai M; Paganini EP
Am J Kidney Dis; 1995 Dec; 26(6):910-7. PubMed ID: 7503065
[TBL] [Abstract][Full Text] [Related]
18. Better correction of metabolic acidosis, blood pressure control, and phagocytosis with bicarbonate compared to lactate solution in acute peritoneal dialysis.
Thongboonkerd V; Lumlertgul D; Supajatura V
Artif Organs; 2001 Feb; 25(2):99-108. PubMed ID: 11251475
[TBL] [Abstract][Full Text] [Related]
19. Continuous venovenous haemofiltration using a citrate buffered substitution fluid.
Schmitz M; Taskaya G; Plum J; Hennersdorf M; Sucker C; Grabensee B; Hetzel GR
Anaesth Intensive Care; 2007 Aug; 35(4):529-35. PubMed ID: 18020071
[TBL] [Abstract][Full Text] [Related]
20. [Insufficient correction of blood bicarbonate levels in biguanide lactic acidosis treated with CVVH and bicarbonate replacement fluids].
Mariano F; Goia F; Vincenti R; Capra L; Lanza G; Curto V; Cavalli PL
Minerva Urol Nefrol; 1997 Sep; 49(3):133-6. PubMed ID: 9432735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
